Control of p53 ubiquitination and nuclear export by MDM2 and ARF
- PMID: 11331246
Control of p53 ubiquitination and nuclear export by MDM2 and ARF
Abstract
p53 and ARF-INK4a are the two most frequently altered loci in human tumors. The activity of p53 protein is inhibited during normal cell growth by the proto-oncoprotein MDM2 through either repression of p53-mediated transcription in the nucleus or proteasomal degradation of p53 protein in the cytoplasm. Responding to oncogenic signal-activated cell hyperproliferation, ARF-mediated antagonism of MDM2 inhibition results in p53 becoming active and its protein levels rising. The biochemical mechanisms of ubiquitination and nuclear export that underlie the functions of ARF and MDM2 in p53 control continue to emerge.
Similar articles
-
The MDM2 RING-finger domain is required to promote p53 nuclear export.Nat Cell Biol. 2000 Sep;2(9):569-73. doi: 10.1038/35023507. Nat Cell Biol. 2000. PMID: 10980696
-
Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.Oncogene. 2004 Nov 25;23(55):8931-40. doi: 10.1038/sj.onc.1208052. Oncogene. 2004. PMID: 15467748
-
Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53.Exp Cell Res. 2001 Oct 15;270(1):66-77. doi: 10.1006/excr.2001.5314. Exp Cell Res. 2001. PMID: 11597128
-
The p53-Mdm2 module and the ubiquitin system.Semin Cancer Biol. 2003 Feb;13(1):49-58. doi: 10.1016/s1044-579x(02)00099-8. Semin Cancer Biol. 2003. PMID: 12507556 Review.
-
Dynamics of ARF regulation that control senescence and cancer.BMB Rep. 2016 Nov;49(11):598-606. doi: 10.5483/bmbrep.2016.49.11.120. BMB Rep. 2016. PMID: 27470213 Free PMC article. Review.
Cited by
-
ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.EMBO J. 2005 Oct 5;24(19):3411-22. doi: 10.1038/sj.emboj.7600812. Epub 2005 Sep 15. EMBO J. 2005. PMID: 16163388 Free PMC article.
-
Conventional and nonconventional roles of the nucleolus.Int Rev Cytol. 2002;219:199-266. doi: 10.1016/s0074-7696(02)19014-0. Int Rev Cytol. 2002. PMID: 12211630 Free PMC article. Review.
-
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials.Signal Transduct Target Ther. 2022 Oct 5;7(1):353. doi: 10.1038/s41392-022-01200-x. Signal Transduct Target Ther. 2022. PMID: 36198685 Free PMC article. Review.
-
Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.Mol Cell Biol. 2003 Dec;23(23):8902-12. doi: 10.1128/MCB.23.23.8902-8912.2003. Mol Cell Biol. 2003. PMID: 14612427 Free PMC article.
-
ATM activates p53 by regulating MDM2 oligomerization and E3 processivity.EMBO J. 2009 Dec 16;28(24):3857-67. doi: 10.1038/emboj.2009.294. EMBO J. 2009. PMID: 19816404 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Molecular Biology Databases
Research Materials
Miscellaneous